Alejandro Ríos-Hoyo

466 total citations
27 papers, 308 citations indexed

About

Alejandro Ríos-Hoyo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Alejandro Ríos-Hoyo has authored 27 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in Alejandro Ríos-Hoyo's work include Cancer Immunotherapy and Biomarkers (5 papers), Advanced Breast Cancer Therapies (4 papers) and Breast Cancer Treatment Studies (4 papers). Alejandro Ríos-Hoyo is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Advanced Breast Cancer Therapies (4 papers) and Breast Cancer Treatment Studies (4 papers). Alejandro Ríos-Hoyo collaborates with scholars based in United States, Spain and Colombia. Alejandro Ríos-Hoyo's co-authors include Gabriela Gutiérrez-Salmeán, Edurne Arriola, Lajos Pusztai, Guillermo Ceballos, Eduardo Meaney, Frederick M. Howard, Alexander T. Pearson, Jenniffer Linares, Joana Vidal and Clara Montagut and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Alejandro Ríos-Hoyo

24 papers receiving 294 citations

Peers

Alejandro Ríos-Hoyo
Kristina J. Liu United States
Kwan‐Il Kim South Korea
Fera Y. Goh Singapore
Henrique Bregolin Dias Brazil
Shang-Jyh Kao Taiwan
Jiayin Yao China
Tao Zhao China
Alexandre Loktionov United Kingdom
G. Weigel Austria
Lavanya Viswanathan United States
Kristina J. Liu United States
Alejandro Ríos-Hoyo
Citations per year, relative to Alejandro Ríos-Hoyo Alejandro Ríos-Hoyo (= 1×) peers Kristina J. Liu

Countries citing papers authored by Alejandro Ríos-Hoyo

Since Specialization
Citations

This map shows the geographic impact of Alejandro Ríos-Hoyo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Ríos-Hoyo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Ríos-Hoyo more than expected).

Fields of papers citing papers by Alejandro Ríos-Hoyo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alejandro Ríos-Hoyo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Ríos-Hoyo. The network helps show where Alejandro Ríos-Hoyo may publish in the future.

Co-authorship network of co-authors of Alejandro Ríos-Hoyo

This figure shows the co-authorship network connecting the top 25 collaborators of Alejandro Ríos-Hoyo. A scholar is included among the top collaborators of Alejandro Ríos-Hoyo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alejandro Ríos-Hoyo. Alejandro Ríos-Hoyo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ríos-Hoyo, Alejandro, et al.. (2025). Clinical Implications of Breast Cancer Intrinsic Subtypes. Advances in experimental medicine and biology. 1464. 435–448. 7 indexed citations
3.
Ríos-Hoyo, Alejandro, et al.. (2025). Clinical, sociodemographic, and facility-related determinants of immunotherapy use in metastatic triple-negative breast cancer. Breast Cancer Research and Treatment. 212(2). 299–308.
4.
Gunasekharan, Vignesh, Michał Marczyk, Alejandro Ríos-Hoyo, et al.. (2024). Phosphoenolpyruvate carboxykinase-2 (PCK2) is a therapeutic target in triple-negative breast cancer. Breast Cancer Research and Treatment. 208(3). 657–671. 2 indexed citations
5.
Ríos-Hoyo, Alejandro, et al.. (2024). Unveiling acquired resistance to anti-EGFR therapies in colorectal cancer: a long and winding road. Frontiers in Pharmacology. 15. 1398419–1398419. 14 indexed citations
6.
Ríos-Hoyo, Alejandro, et al.. (2024). Evaluation of large language models as a diagnostic aid for complex medical cases. Frontiers in Medicine. 11. 1380148–1380148. 29 indexed citations
7.
Bartoletti, Michele, Ivan Bièche, Giuseppe Curigliano, et al.. (2024). Multi-Institutional Evaluation of Interrater Agreement of Biomarker-Drug Pair Rankings Based on the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) and Sources of Discordance. Molecular Diagnosis & Therapy. 29(1). 91–101. 1 indexed citations
8.
Ríos-Hoyo, Alejandro, Jiawei Dai, Christina Yau, et al.. (2024). Hormone Receptor–Positive HER2-Negative/MammaPrint High-2 Breast Cancers Closely Resemble Triple-Negative Breast Cancers. Clinical Cancer Research. 31(2). 403–413. 2 indexed citations
9.
Ríos-Hoyo, Alejandro, Erin F. Cobain, Laura A. Huppert, et al.. (2024). Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor–Positive Human Epidermal Growth Factor 2–Negative Breast Cancer. Journal of Clinical Oncology. 42(22). 2632–2636. 10 indexed citations
10.
Visa, Laura, et al.. (2023). Prognostic factors in oncological patients with solid tumours requiring intensive care unit admission. Oncology Letters. 26(6). 525–525. 2 indexed citations
11.
Ríos-Hoyo, Alejandro & Edurne Arriola. (2023). Immunotherapy and brain metastasis in lung cancer: connecting bench side science to the clinic. Frontiers in Immunology. 14. 1221097–1221097. 17 indexed citations
12.
Nathanson, David, Lothar C. Dieterich, Xiang H.-F. Zhang, et al.. (2023). Associations amongst genes, molecules, cells, and organs in breast cancer metastasis. Clinical & Experimental Metastasis. 41(4). 417–437. 5 indexed citations
13.
Rodríguez‐Vida, Alejo, Pablo Maroto, Albert Font, et al.. (2022). Safety and efficacy of avelumab plus carboplatin in patients with metastatic castration-resistant prostate cancer in an open-label Phase Ib study. British Journal of Cancer. 128(1). 21–29. 9 indexed citations
14.
Ríos-Hoyo, Alejandro, et al.. (2017). Prehispanic Functional Foods and Nutraceuticals in the Treatment of Dyslipidemia Associated to Cardiovascular Disease: a Mini-Review. International Journal for Vitamin and Nutrition Research. 87(1-2). 85–98. 9 indexed citations
15.
Sahasrabudhe, Ruta, Ana P. Estrada-Florez, Paul C. Lott, et al.. (2015). The 8q24 rs6983267G variant is associated with increased thyroid cancer risk. Endocrine Related Cancer. 22(5). 841–849. 15 indexed citations
16.
Ríos-Hoyo, Alejandro, et al.. (2014). Obesity, Metabolic Syndrome, and Dietary Therapeutical Approaches with a Special Focus on Nutraceuticals (Polyphenols): A Mini-Review. International Journal for Vitamin and Nutrition Research. 84(3-4). 113–123. 41 indexed citations
17.
Roldán-Valadéz, Ernesto, et al.. (2014). Variability of apparent diffusion coefficients in metastatic small cell lung carcinoma: comparisons between-within normal tissue and liver metastases. Annals of Hepatology. 13(2). 297–302. 3 indexed citations
18.
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristina J. Liu Breakdown of academic impact, for papers by Kwan‐Il Kim Breakdown of academic impact, for papers by Fera Y. Goh Breakdown of academic impact, for papers by Henrique Bregolin Dias Breakdown of academic impact, for papers by Shang-Jyh Kao Breakdown of academic impact, for papers by Jiayin Yao Breakdown of academic impact, for papers by Tao Zhao Breakdown of academic impact, for papers by Alexandre Loktionov Breakdown of academic impact, for papers by G. Weigel Breakdown of academic impact, for papers by Lavanya Viswanathan
Rankless by CCL
2026